Peak Scientific (Inchinnan, Scotland) has been awarded a 2014 Queen?s Award for Enterprise in International Trade decreed by Her Majesty The Queen of Great Britain, on the recommendation of the Prime Minister, David Cameron. The awards are announced each year on the Queen?s birthday, 21 April.
Peak Scientific (Inchinnan, Scotland) has been awarded a 2014 Queen’s Award for Enterprise in International Trade decreed by Her Majesty The Queen of Great Britain, on the recommendation of the Prime Minister, David Cameron. The awards are announced each year on the Queen’s birthday, 21 April.
This is the fourth time that the company has received this award in recognition of its international trade and growth overseas. Established in 1997, the company is now supported by a network of distributors and service partners in 70 countries worldwide. Each award is valid for five years, and winners are invited to a reception with HM The Queen at Buckingham Palace in London, UK.
Peak Scientific MD, Robin MacGeachy, said: “Innovation and client service are at the heart of all we do, and this requires investment in quality materials and smart people across all areas of the business, at home and abroad.” He added: “Our products are now exported to just about every major market in the world and reliability is critical to many of our customers. In keeping with our brand promise, we offer the industry’s best after-sales care with a 95% first-time fix record and a commitment to have a Peak engineer on a client’s door-step to solve any issues within 72 hours… anywhere on the planet.”
For more information visit: www.queensawards.org.uk
Assessing Safety of Medications During Pregnancy and Breastfeeding with LC–MS/MS
Published: April 8th 2025 | Updated: April 8th 2025Researchers conducted a study on medications used in psychiatry and neurology during the perinatal period, assessing how antiepileptic drugs (AEDs) affect placental functions, including transport mechanisms, nutrient transport, and trophoblast differentiation. Several quantitative methods, such as those for antianxiety and hypnotic drugs, were established to evaluate the safety of pharmacotherapy during breastfeeding using liquid chromatography-tandem mass spectrometry (LC–MS/MS).